PHF20
Basic information
Region (hg38): 20:35771974-35950370
Previous symbols: [ "C20orf104" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHF20 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 34 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 34 | 0 | 7 |
Variants in PHF20
This is a list of pathogenic ClinVar variants found in the PHF20 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-35801593-G-A | not specified | Uncertain significance (Jan 04, 2024) | ||
20-35842676-C-T | not specified | Uncertain significance (Jul 17, 2023) | ||
20-35842680-A-G | not specified | Uncertain significance (Dec 03, 2024) | ||
20-35847411-A-G | not specified | Uncertain significance (Jul 20, 2021) | ||
20-35858376-G-C | not specified | Uncertain significance (Nov 20, 2024) | ||
20-35863240-C-T | Benign (Oct 09, 2017) | |||
20-35863296-C-A | not specified | Uncertain significance (Aug 16, 2022) | ||
20-35863337-C-T | not specified | Uncertain significance (Mar 11, 2024) | ||
20-35869446-T-C | not specified | Uncertain significance (Mar 23, 2022) | ||
20-35869519-C-T | Short stature | Likely pathogenic (Nov 18, 2001) | ||
20-35870979-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
20-35870993-A-C | not specified | Uncertain significance (May 13, 2024) | ||
20-35871032-A-G | not specified | Uncertain significance (Jul 14, 2024) | ||
20-35871087-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
20-35871682-G-T | not specified | Uncertain significance (Oct 29, 2021) | ||
20-35871703-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
20-35871715-G-C | not specified | Uncertain significance (Jun 29, 2022) | ||
20-35871757-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
20-35871773-T-C | not specified | Uncertain significance (Jul 26, 2024) | ||
20-35871785-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
20-35871796-C-G | not specified | Uncertain significance (Jan 16, 2024) | ||
20-35899426-G-A | not specified | Uncertain significance (Sep 11, 2024) | ||
20-35899548-G-C | not specified | Uncertain significance (Mar 07, 2024) | ||
20-35899556-G-A | not specified | Uncertain significance (May 15, 2024) | ||
20-35899609-G-C | not specified | Uncertain significance (Dec 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PHF20 | protein_coding | protein_coding | ENST00000374012 | 17 | 178408 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00125 | 125732 | 0 | 14 | 125746 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.35 | 399 | 555 | 0.719 | 0.0000300 | 6681 |
Missense in Polyphen | 105 | 179.73 | 0.5842 | 2215 | ||
Synonymous | 1.58 | 185 | 215 | 0.862 | 0.0000119 | 1858 |
Loss of Function | 5.66 | 7 | 50.3 | 0.139 | 0.00000251 | 647 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000906 | 0.0000905 |
Ashkenazi Jewish | 0.000210 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000626 | 0.0000615 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000382 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Methyllysine-binding protein, component of the MOF histone acetyltransferase protein complex. Not required for maintaining the global histone H4 'Lys-16' acetylation (H4K16ac) levels or locus specific histone acetylation, but instead works downstream in transcriptional regulation of MOF target genes (By similarity). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. Contributes to methyllysine-dependent p53/TP53 stabilization and up-regulation after DNA damage. {ECO:0000250, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:22864287}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Chromatin modifying enzymes;Cell Cycle Checkpoints;HATs acetylate histones;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Chromatin organization;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Activity;Transcriptional Regulation by TP53;Cell Cycle
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- 0.407
- rvis_EVS
- -0.55
- rvis_percentile_EVS
- 19.86
Haploinsufficiency Scores
- pHI
- 0.597
- hipred
- Y
- hipred_score
- 0.708
- ghis
- 0.600
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.838
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phf20
- Phenotype
- skeleton phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;histone H4-K5 acetylation;histone H4-K8 acetylation;histone H4-K16 acetylation;regulation of signal transduction by p53 class mediator
- Cellular component
- histone acetyltransferase complex;nucleoplasm;cytosol;nuclear membrane;MLL1 complex
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase activity (H4-K8 specific);metal ion binding;histone acetyltransferase activity (H4-K16 specific)